OmpG Nanopore Biosensor Heterologous Peptide Gating

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for the rapid and selective detection of biomolecular indicators of disease, or biomarkers, are hindered by the complexity of patient samples and the vast repertoire of potential compounds, making cost-effective and accurate diagnostics challenging.

Innovation Solution

A nanopore-based biosensor using outer membrane protein G (OmpG) with heterologous peptides inserted into flexible loops, which alters its gating pattern upon binding to targets, allowing for the detection of specific ligands through changes in ionic current flow.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional methods are used for biomarker detection, then detection capability is limited, but device complexity and cost increase

Engineering Contradiction:
Improvebiomarker detection sensitivityVSAvoiddetection system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent modifies the physical-chemical parameters of the nanopore by inserting heterologous peptides with specific sequences into flexible loops of OmpG. These parameter changes enable the nanopore to selectively bind target biomarkers, achieving high sensitivity detection without complex instrumentation

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The heterologous peptide acts as an intermediary element that mediates the interaction between the nanopore and target biomarker. The peptide sequence is designed to specifically bind to the target, translating molecular recognition into measurable electrical signal changes

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If selective multiplex detection is implemented, then diagnostic accuracy improves, but manufacturing complexity increases

Engineering Contradiction:
Improvediagnostic accuracyVSAvoidnanopore production simplicity
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent divides the detection function into separate modular components by inserting different heterologous peptides into different flexible loops of OmpG. Each loop-peptide combination can independently detect a specific biomarker, enabling multiplex detection while maintaining straightforward nanopore production

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The OmpG nanopore platform provides universal functionality for detecting multiple different biomarkers by simply changing the heterologous peptide sequence inserted into the flexible loops. This multi-functionality is achieved through a single, well-characterized protein scaffold

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Speed

If real-time detection at nanomolar concentrations is achieved, then diagnostic timeliness improves, but measurement precision requirements increase

Engineering Contradiction:
Improvedetection speedVSAvoidconcentration detection accuracy
Core Design Contradiction:
SpeedVSMeasurement precision

Solution Approach 1:

The patent replaces complex mechanical or optical detection systems with an electrical measurement approach. The binding event between heterologous peptide and target biomarker directly modulates ionic current through the nanopore, enabling real-time detection with high concentration accuracy through simple electrical measurements

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables sensitive, real-time detection of biomarkers at nanomolar concentrations with high specificity, facilitating accurate diagnostics and optimal treatment decisions.

Implementation Method 1

detecting specific ligands through changes in ionic current flow

Methodology Applied
Scientific EffectIonic current flow: Conduction (electrical)

Implementation Method 2

alters its gating pattern upon binding to targets

Methodology Applied
Scientific EffectGating pattern alteration:

Data Source

PatentUS20240036027A1Nanopore Biosensors and Uses Thereof
Publication Date: 2024.02.01 UNIV OF MASSACHUSETTS
  • US20240036027A1 patent drawing
  • US20240036027A1 patent drawing
  • US20240036027A1 patent drawing

AI summary

Disclosed herein is a composition that involves a nanopore disposed in a membrane preparation, wherein the nanopore has an outer membrane protein G (OmpG) having 8 to 22 β-strands connected by a plurality of flexible loops on a first side of the membrane preparation and a plurality short turns on a second side of the membrane preparation, wherein a heterologous peptide is inserted within one or more of the flexible loops. Also disclosed herein is a method of detecting binding of a ligand to a target, the method involving: exposing a nanopore composition disclosed herein to a target; assessing a gating pattern of the nanopore; and detecting binding of the target to the heterologous peptide based on the gating pattern.